This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody, International Journal of Diabetes in Developing Countries, September 2011, Springer Science + Business Media,
DOI: 10.1007/s13410-011-0042-2.
You can read the full text:
The following have contributed to this page
